Literature DB >> 30712797

Essential TNM: a registry tool to reduce gaps in cancer staging information.

Marion Piñeros1, D Maxwell Parkin2, Kevin Ward3, Eric Chokunonga4, Morten Ervik5, Helen Farrugia6, Mary Gospodarowicz7, Brian O'Sullivan7, Isabelle Soerjomataram5, Rajaraman Swaminathan8, Ariana Znaor5, Freddie Bray5, James Brierley7.   

Abstract

Accurate information on the extent of disease around the time of diagnosis is an important component of cancer care, in defining disease prognosis, and evaluating national and international cancer control policies. However, the collection of stage data by population-based cancer registries remains a challenge in both high-income and low and middle-income countries. We emphasise the lack of availability and comparability of staging information in many population-based cancer registries and propose Essential TNM, a simplified staging system for cancer registries when information on full Tumour, Node, Metastasis (TNM) is absent. Essential TNM aims at staging cancer in its most advanced disease form by summarising the extent of disease in the order of distant metastasis (M), regional lymph node involvement (N), and tumour size or extension, or both (T). Flowcharts and rules have been developed for coding these elements in breast, cervix, prostate, and colon cancers, and combining them into stage groups (I-IV) that correspond to those obtained by full TNM staging. Essential TNM is comparable to the Union for International Cancer Control TNM stage groups and is an alternative to providing staging information by the population-based cancer registries that complies with the objectives of the Global Initiative for Cancer Registry Development.
Copyright © 2019 International Agency for Research in Cancer. Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30712797     DOI: 10.1016/S1470-2045(18)30897-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  13 in total

1.  The mediating role of appraisal on health-related quality of life in adolescent and young adult cancer survivors.

Authors:  Renjun Gu; Hao Chen; Xian Wang; Xiaoyuan Jin; Fengyang Jiang; Wenhe Zhao; Jingyi Yun; Jie Zhou; Hongmei Wang
Journal:  Qual Life Res       Date:  2022-10-19       Impact factor: 3.440

2.  CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells.

Authors:  Tamilarasan K Palaniappan; Lina Šlekienė; Anna-Karin Jonasson; Jonathan Gilthorpe; Lena Gunhaga
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

3.  Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.

Authors: 
Journal:  Lancet       Date:  2021-01-21       Impact factor: 202.731

4.  Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival.

Authors:  Daniel X Yang; Rohan Khera; Joseph A Miccio; Vikram Jairam; Enoch Chang; James B Yu; Henry S Park; Harlan M Krumholz; Sanjay Aneja
Journal:  JAMA Netw Open       Date:  2021-03-01

5.  Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.

Authors:  Anton Ryzhov; Marilys Corbex; Marion Piñeros; Anton Barchuk; Diana Andreasyan; Sayde Djanklich; Vadim Ghervas; Olga Gretsova; Dilyara Kaidarova; Konstantin Kazanjan; Fuad Mardanli; Yuriy Michailovich; Elena Ten; Alesya Yaumenenka; Freddie Bray; Ariana Znaor
Journal:  Lancet Oncol       Date:  2021-02-05       Impact factor: 41.316

6.  AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.

Authors:  Rafael Adrián Pacheco-Orozco; Lorena Montealegre-Páez; Federico Cayol; Héctor Martínez-Gregorio; Javier Oliver; Cecilia Frecha; Felipe Vaca-Paniagua; Sandra Perdomo
Journal:  Oncologist       Date:  2020-08-19

Review 7.  Global Consultation on Cancer Staging: promoting consistent understanding and use.

Authors:  James Brierley; Brian O'Sullivan; Hisao Asamura; David Byrd; Shao Hui Huang; Anne Lee; Marion Piñeros; Malcolm Mason; Fabio Y Moraes; Wiebke Rösler; Brian Rous; Julie Torode; J Han van Krieken; Mary Gospodarowicz
Journal:  Nat Rev Clin Oncol       Date:  2019-08-06       Impact factor: 66.675

8.  Isobaric Tags for Relative and Absolute Quantitation in Proteomic Analysis of Potential Biomarkers in Invasive Cancer, Ductal Carcinoma In Situ, and Mammary Fibroadenoma.

Authors:  Hao Wu; Xian-Yu Zhang; Ming Niu; Fei-Feng Li; Song Gao; Wei Wei; Si-Wei Li; Xing-Da Zhang; Shu-Lin Liu; Da Pang
Journal:  Front Oncol       Date:  2020-10-21       Impact factor: 6.244

9.  Estimation of Risk of Recurrence and Toxicity Among Oncologists and Patients With Resected Breast Cancer: A Quantitative Study.

Authors:  Laura Ciria-Suarez; Paula Jimenez-Fonseca; Raquel Hernández; Jacobo Rogado; Caterina Calderon
Journal:  Front Psychol       Date:  2020-10-27

10.  Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.

Authors:  Xuemei Yang; Juan Li; Yifan Wang; Peilong Li; Yinghui Zhao; Weili Duan; Abakundana Nsenga Ariston Gabriel; Yingjie Chen; Haiting Mao; Yunshan Wang; Lutao Du; Chuanxin Wang
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.